
Cell Reprogramming in Hematopoiesis and Immunity. @LuWcmm @Lund_Stem @lunduniversity. Tweets by Filipe Pereira (signed FP) and Malavika Nair (for CFP lab).
Lund, Sverige
Joined June 2016
- Tweets665
- Following1.4K
- Followers2.4K
- Likes824
11) Our proposed model:
· Tumor-to-cDC1 reprogramming induces mature imgTLSs across cancers
· cDC1-like cells orchestrate TLS formation by interacting with T cells
· imgTLSs coordinate T-cell and B-cell immunity
· Local immune remodeling drives systemic anti-tumor responses
1
53
10) Remarkably, humoral immunity was also enhanced. imgTLSs supported durable tumor-specific antibody responses, highlighting a role for B-cell immunity in long-term tumor control.
1
54
9) ImgTLSs promoted systemic immunity beyond the treated tumor. We observed expansion of shared T-cell clonotypes in distant untreated tumors, indicating broad anti-tumor immune responses.
1
56
8) Migratory DC-LAMP⁺CCR7⁺ cDC1s act as organizers of immune niches enriched for T cells and B cells.
1
61
7) Spatial transcriptomics and imaging of imgTLSs revealed that DCs acquire conserved spatially restricted resident and migratory signaling programs in TLS-containing tumors. Both proximal and distal DC subsets promote rapid induction of lymphotoxin, TNFα, and CD40.
1
77
6) How does this happen? Reprogrammed cDC1-like cells interact with T cells through MHC class I and CD40 signaling to drive imgTLS formation.
1
72
5) Of note: reprogramming cancer cells into cDC1-like cells rapidly induced mature immunogenic TLSs with germinal centers in melanoma, colon, bladder, breast, and pancreatic cancer models. This happened independently of endogenous cDC1s and correlated with long-term survival.
1
98
4) First, we show that tumor-to-cDC1 reprogramming immunotherapy is effective across tumor contexts, including immunosuppressive environments such as brain tumors, and synergizes with anti-PD-1 in refractory tumors.
1
100
We asked whether tumor-to-cDC1 reprogramming could be used to induce immunogenic TLSs (imgTLSs) within tumors. We tested the tumor-origin-agnostic nature of the strategy, identified drivers of imgTLS formation, and pinpointed the effectors of induced anti-tumor immunity.
1
203
1) 📢 New study out in @ImmunityCP : We show that tumor-to-cDC1 reprogramming induces tertiary lymphoid structures (TLSs) across cancers. Read it here:sciencedirect.com/science/ar…. A thread 🧵
#TLS #reprogramming #immunotherapy
Graphical abstract by Avesta Rastan.











